source
- Western pharma firms lobby Trump administration to preserve China partnership opportunitiesWestern pharmaceutical companies are urging the Trump administration to permit continued collaborations with Chinese firms on promising drug candidates, despite a 2025 law that limits U.S. investme…
- Regulators Share Guidance for Effective Sponsor MeetingsRegulators from the U.S. FDA, the U.K. MHRA and other European agencies met to outline best practices for sponsor‑regulator interactions. They highlighted that transparency, open collaboration, at…